Back to search

Belgium· BE-AMP-SAM230045-00

Vidisic Edo 2 mg/g

A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carbomers, registered in Belgium by Bausch & Lomb Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC S01XA20

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVidisic Edo 2 mg/gATCS01XA20REGISTER NO.BE-AMP-SAM230045-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.

Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Carbomers
Manufacturer
Bausch & Lomb Pharma
Country
Belgium (BE)
ATC code
S01XA20
ATC class
Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1686534

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2d2ad5a-01ab-4da5-8978-3f669ca12499
GET /v1/drugs/f2d2ad5a-01ab-4da5-8978-3f669ca12499?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye gel",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Vidisic Edo 2 mg/g",
  "name_fr": "Vidisic Edo 2 mg/g",
  "name_nl": "Vidisic Edo 2 mg/g",
  "amp_code": "SAM230045-00",
  "strengths": [
    "2.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Carbomers"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Artificial Tears and Other Indifferent Preparations",
  "authorisation_numbers": [
    "BE230045"
  ]
}

See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.